Access cutting-edge bronchopulmonary dysplasia (bpd) treatment through this clinical trial at a research site in Greenville. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Greenville location
Preparing your pre-screening questions…
Access bronchopulmonary dysplasia (bpd) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bronchopulmonary dysplasia (bpd) treatment provided free
Check if you qualify for this bronchopulmonary dysplasia (bpd) clinical trial in Greenville, NC
No-Cost Study Care
Local to Greenville
Convenient for NC residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The purpose of the study is to learn how safe montelukast may be in premature infants at significant risk for Bronchopulmonary Dysplasia (BPD) and to determine how much and how quickly montelukast moves from the stomach into the bloodstream, and how quickly it is removed from the bloodstream. Data supporting the prospect of montelukast benefit involved 6 previous studies involving 206 preterm infants. The dosing ranged from 0.5 to 2.5 mg/kg/day, which aligns with the proposed initial dose of 0.75 mg/kg/day. Though each previous study had a small population, collectively they reveal montelukast as a promising drug in populations of preterm infants developing BPD and for individual preterm infants who are "developing BPD." Thus, researchers expect clinical benefit for preterm infants in this study. Despite the benefit-to-risk ratio presented by these previous studies, the optimal dose remains to be determined; thus, this study design and PK analysis will start with the lowest dose that is likely to provide direct benefit to participants.
Sponsor: Duke University
Yes, this clinical trial (NCT07101640) has an active research site in Greenville, NC that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for bronchopulmonary dysplasia (bpd) treatment options in Greenville, NC, this clinical trial (NCT07101640) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Greenville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bronchopulmonary dysplasia (bpd) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all bronchopulmonary dysplasia (bpd) clinical trials near you to find additional studies recruiting in your area.
See all parkinsons disease clinical trials recruiting in Greenville — not just this study.
Browse Parkinsons Disease Trials in Greenville →